Splice isoforms of human interleukin-4 are functionally active in mice in vivo

Immunology

Volumn 132, Issue 3, 2011, Pages 385-393

  Luzina, Irina G ^a,b   Lockatell, Virginia ^a   Todd, Nevins W ^a,b   Keegan, Achsah D ^a   Hasday, Jeffrey D ^a,b   Atamas, Sergei P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Alternative splicing; Cytokines; Inflammation; Interleukin 4; Lung; Lymphocytes

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR TYPE II; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; B LYMPHOCYTE; CONTROLLED STUDY; EXON; FEMALE; GENE TARGETING; IN VIVO STUDY; LUNG INFILTRATE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

ALTERNATIVE SPLICING; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED C57BL; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY;

EID: 79251607761     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03393.x     Document Type: Article

References (32)

1. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17:701-38.
2. Corry DB, Kheradmand F. Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma. Am J Respir Med 2002; 1:185-93.
3. Finkelman FD, Shea-Donohue T, Morris SC, Gildea L, Strait R, Madden KB, Schopf L, Urban JF. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 2004; 201:139-55.
4. Rook GA, Hernandez-Pando R, Dheda K, Seah GT. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol 2004; 25:483-8.
5. Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol Res 2004; 30:339-49.
6. + lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999; 42:1168-78.
7. Mosmann TR, Yokota T, Kastelein R, Zurawski SM, Arai N, Takabe Y. Species-specificity of T cell stimulating activities of IL-2 and BSF-1 (IL-4): comparison of normal and recombinant, mouse and human IL-2 and BSF-1 (IL-4). J Immunol 1987; 138:1813-6.
8. Myburgh E, Horsnell WGC, Cutler AJ, Arendse B, Kubo M, Brombacher F. Murine IL-4 is able to signal via chimeric human IL-4Rα/mouse γ-chain receptor. Mol Immunol 2008; 45:1327-36.
9. Wang Y, Shen BJ, Sebald W. A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor α chain. Proc Natl Acad Sci U S A 1997; 94:1657-62.
10. Baumhofer JM, Beinhauer BG, Wang JE et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur J Immunol 1998; 28:610-5.
11. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. J Exp Med 1998; 188:1039-46.
12. Fukushi J, Ono M, Morikawa W, Iwamoto Y, Kuwano M. The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. J Immunol 2000; 165:2818-23.
13. Alms WJ, Atamas SP, Yurovsky VV, White B. Generation of a variant of human interleukin-4 by alternative splicing. Mol Immunol 1996; 33:361-70.
14. Atamas SP, Choi J, Yurovsky VV, White B. An alternative splice variant of human IL-4, IL-4δ2, inhibits IL-4-stimulated T cell proliferation. J Immunol 1996; 156:435-41.
15. Gautherot I, Burdin N, Seguin D, Aujame L, Sodoyer R. Cloning of interleukin-4δ2 splice variant (IL-4δ2) in chimpanzee and cynomolgus macaque: phylogenetic analysis of δ2 splice variant appearance, and implications for the study of IL-4-driven immune processes. Immunogenetics 2002; 54:635-44.
16. Yatsenko OP, Filipenko ML, Khrapov EA, Voronina EN, Kozlov VA, Sennikov SV. Alternative splicing of mRNA of mouse interleukin-4 and interleukin-6. Cytokine 2004; 28:190-6.
17. Waldvogel AS, Lepage MF, Zakher A, Reichel MP, Eicher R, Heussler VT. Expression of interleukin 4, interleukin 4 splice variants and interferon gamma mRNA in calves experimentally infected with Fasciola hepatica. Vet Immunol Immunopathol 2004; 97:53-63.
18. Sakkas LI, Tourtellotte C, Berney S, Myers AR, Platsoucas CD. Increased levels of alternatively spliced interleukin 4 (IL-4δ2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis. Clin Diagn Lab Immunol 1999; 6:660-4.
19. Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181:385-9.
20. Fletcher HA, Owiafe P, Jeffries D et al. Vacsel Study Group. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 2004; 112:669-73.
21. Dheda K, Chang JS, Breen RA et al. In vivo and in vitro studies of a novel cytokine, interleukin 4δ2, in pulmonary tuberculosis. Am J Respir Crit Care Med 2005; 172:501-8.
22. Glare EM, Divjak M, Rolland JM, Walters EH. Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-4δ2. J Allergy Clin Immunol 1999; 104:978-82.
23. Plante S, Semlali A, Joubert P, Bissonnette E, Laviolette M, Hamid Q, Chakir J. Mast cells regulate procollagen I (α 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4δ2 ratio. J Allergy Clin Immunol 2006; 117:1321-7.
24. Wu HP, Wu CL, Chen CK, Chung K, Tseng JC, Liu YC, Chuang DY. The interleukin-4 expression in patients with severe sepsis. J Crit Care 2008; 23:519-24.
25. Luzina IG, Papadimitriou JC, Anderson R, Pochetuhen K, Atamas SP. Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum 2006; 54:2643-55.
26. Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP. Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol 2007; 171:428-37.
27. Luzina IG, Todd NW, Nacu N, Lockatell V, Choi J, Hummers LK, Atamas SP. Regulation of pulmonary inflammation and fibrosis through expression of integrins αVβ3 and αVβ5 on pulmonary T lymphocytes. Arthritis Rheum 2009; 60:1530-9.
28. Kelly-Welch AE, Melo ME, Smith E, Ford AQ, Haudenschild C, Noben-Trauth N, Keegan AD. Complex role of the IL-4 receptor α in a murine model of airway inflammation: expression of the IL-4 receptor α on nonlymphoid cells of bone marrow origin contributes to severity of inflammation. J Immunol 2004; 172:4545-55.
29. Kelly-Welch AE, Wang HY, Wang LM, Pierce JH, Jay G, Finkelman F, Keegan AD. Transgenic expression of insulin receptor substrate 2 in murine B cells alters the cell density-dependence of IgE production in vitro and enhances IgE production in vivo. J Immunol 2004; 172:2803-10.
30. + precursors. J Immunol 2005; 175:6107-16.
31. Bachtarzi H, Stevenson M, Fisher K. Cancer gene therapy with targeted adenoviruses. Expert Opin Drug Deliv 2008; 5:1231-40.
32. Arinobu Y, Atamas SP, Otsuka T et al. Antagonistic effects of an alternative splice variant of human IL-4, IL-4δ2, on IL-4 activities in human monocytes and B cells. Cell Immunol 1999; 191:161-7.